Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Pesce

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|January 5, 2023
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the artNicoletta Provinciali, Marco Greppi, Silvia Pesce, et al.
International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Frontiers in Immunology|December 24, 2019
Harnessing NK Cells for Cancer TreatmentPaola Minetto, Fabio Guolo, Silvia Pesce, et al.
Mucosal Immunology|February 14, 2019
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human deciduaPaola Vacca, Silvia Pesce, Marco Greppi, et al.
Frontiers in Immunology|December 16, 2024
Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control studyFederico Rebaudi, Alberto Rebaudi, Alfredo De Rosa, et al.
Oncoimmunology|July 3, 2015
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escapeSilvia Pesce, Giovanna Tabellini, Claudia Cantoni, et al.
Frontiers in Immunology|October 31, 2018
New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR ExpressionSilvia Pesce, Margherita Squillario, Marco Greppi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2024
Deletion of the <i>TMEM30A</i> gene enables leukemic cell evasion of NK cell cytotoxicityLinnea Kristenson, Chiara Badami, Angelica Ljungberg, et al.
Frontiers in Cell and Developmental Biology|March 13, 2020
miRNAs in NK Cell-Based Immune Responses and Cancer ImmunotherapySilvia Pesce, Marco Greppi, Elisa Ferretti, et al.
Cancers|December 16, 2020
Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors SurveillanceElisa Ferretti, Simona Carlomagno, Silvia Pesce, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|January 5, 2023
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the artNicoletta Provinciali, Marco Greppi, Silvia Pesce, et al.
International Journal of Molecular Sciences|February 23, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian CancerMarco Greppi, Giovanna Tabellini, Ornella Patrizi, et al.
Frontiers in Immunology|December 24, 2019
Harnessing NK Cells for Cancer TreatmentPaola Minetto, Fabio Guolo, Silvia Pesce, et al.
Mucosal Immunology|February 14, 2019
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human deciduaPaola Vacca, Silvia Pesce, Marco Greppi, et al.
Frontiers in Immunology|December 16, 2024
Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control studyFederico Rebaudi, Alberto Rebaudi, Alfredo De Rosa, et al.
Oncoimmunology|July 3, 2015
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escapeSilvia Pesce, Giovanna Tabellini, Claudia Cantoni, et al.
Frontiers in Immunology|October 31, 2018
New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR ExpressionSilvia Pesce, Margherita Squillario, Marco Greppi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2024
Deletion of the <i>TMEM30A</i> gene enables leukemic cell evasion of NK cell cytotoxicityLinnea Kristenson, Chiara Badami, Angelica Ljungberg, et al.
Frontiers in Cell and Developmental Biology|March 13, 2020
miRNAs in NK Cell-Based Immune Responses and Cancer ImmunotherapySilvia Pesce, Marco Greppi, Elisa Ferretti, et al.
Cancers|December 16, 2020
Role of the Main Non HLA-Specific Activating NK Receptors in Pancreatic, Colorectal and Gastric Tumors SurveillanceElisa Ferretti, Simona Carlomagno, Silvia Pesce, et al.
Pageof 6